PEDIATRICS Vol. 79 No. 4 April 1987, pp. 593-597
This Article
Right arrow Full Text (PDF)
Right arrow P3Rs: Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when P3Rs are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow E-mail this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My File Cabinet
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via CrossRef
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Olness, K.
Right arrow Articles by Uden, D. L.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Olness, K.
Right arrow Articles by Uden, D. L.

Comparison of Self-Hypnosis and Propranolol in the Treatment of Juvenile Classic Migraine

Karen Olness MD1, John T. MacDonald MD1, and Donald L. Uden PharmD1

1 The Departments of Pediatric Neurology, Behavioral Pediatrics and Research, and Pharmacy, Minneapolis Children's Medical Center, Minneapolis

In a prospective study we compared propranolol, placebo, and self-hypnosis in the treatment of juvenile classic migraine. Children aged 6 to 12 years with classic migraine who had no previous specific treatment were randomized into propranolol (at 3 mg/kg/d) or placebo groups for a 3-month period and then crossed over for 3 months. After this 6-month period, each child was taught self-hypnosis and used it for 3 months. Twenty-eight patients completed the entire study. The mean number of headaches per child for 3 months during the placebo period was 13.3 compared with 14.9 during the propranolol period and 5.8 during the self-hypnosis period. Statistical analysis showed a significant association between decrease in headache frequency and self-hypnosis training (P = .045). There was no significant change in subjective or objective measures of headache severity with either therapy.

Key Words: migraine • propranolol • self-hypnosis • pain

Submitted on March 7, 1986
Accepted on May 13, 1986




This article has been cited by other articles:


Home page
EDUCATION AND PRACTICEHome page
R W Newton
Childhood headache
Arch. Dis. Child. Ed. Pract., August 1, 2008; 93(4): 105 - 111.
[Full Text] [PDF]


Home page
J Child NeurolHome page
A. Pakalnis
Current Therapies in Childhood and Adolescent Migraine
J Child Neurol, November 1, 2007; 22(11): 1288 - 1292.
[Abstract] [PDF]


Home page
J Child NeurolHome page
J. A. Cvengros, D. Harper, and M. Shevell
Pediatric Headache: An Examination of Process Variables in Treatment
J Child Neurol, October 1, 2007; 22(10): 1172 - 1181.
[Abstract] [PDF]


Home page
PediatricsHome page
H. Saadat and Z. N. Kain
Hypnosis as a Therapeutic Tool in Pediatrics
Pediatrics, July 1, 2007; 120(1): 179 - 181.
[Full Text] [PDF]


Home page
The Annals of PharmacotherapyHome page
L. S Eiland, L. S Jenkins, and S. H Durham
Pediatric Migraine: Pharmacologic Agents for Prophylaxis
Ann. Pharmacother., July 1, 2007; 41(7): 1181 - 1190.
[Abstract] [Full Text] [PDF]


Home page
cfpHome page
A. L. Rogovik and R. D. Goldman
Hypnosis for treatment of pain in children
Can Fam Physician, May 1, 2007; 53(5): 823 - 825.
[Abstract] [Full Text] [PDF]


Home page
J Pediatr PsycholHome page
M. Connelly, M. A. Rapoff, N. Thompson, and W. Connelly
Headstrong: A Pilot Study of a CD-ROM Intervention for Recurrent Pediatric Headache
J. Pediatr. Psychol., August 1, 2006; 31(7): 737 - 747.
[Abstract] [Full Text] [PDF]


Home page
EDUCATION AND PRACTICEHome page
N P Barnes and S Jayawant
MIGRAINE
Arch. Dis. Child. Ed. Pract., October 1, 2005; 90(3): ep53 - ep57.
[Full Text] [PDF]


Home page
Evid Based Complement Alternat MedHome page
J. C. I. Tsao and L. K. Zeltzer
Complementary and Alternative Medicine Approaches for Pediatric Pain: A Review of the State-of-the-science
Evid. Based Complement. Altern. Med., June 1, 2005; 2(2): 149 - 159.
[Abstract] [Full Text] [PDF]


Home page
Clinical Child Psychology and PsychiatryHome page
S. W. Powers, J. S. Jones, and B. A. Jones
Behavioral and Cognitive-Behavioral Interventions with Pediatric Populations
Clinical Child Psychology and Psychiatry, January 1, 2005; 10(1): 65 - 77.
[Abstract] [PDF]


Home page
NeurologyHome page
D. Lewis, S. Ashwal, A. Hershey, D. Hirtz, M. Yonker, and S. Silberstein
Practice Parameter: Pharmacological treatment of migraine headache in children and adolescents: Report of the American Academy of Neurology Quality Standards Subcommittee and the Practice Committee of the Child Neurology Society
Neurology, December 28, 2004; 63(12): 2215 - 2224.
[Abstract] [Full Text] [PDF]


Home page
Arch. Dis. Child.Home page
N Barnes and G Millman
Do pizotifen or propranolol reduce the frequency of migraine headache?
Arch. Dis. Child., July 1, 2004; 89(7): 684 - 685.
[Full Text]


Home page
DTBHome page
Managing migraine in children
DTB, April 1, 2004; 42(4): 25 - 28.
[Abstract] [Full Text] [PDF]


Home page
NEJMHome page
C. B. Berde and N. F. Sethna
Analgesics for the Treatment of Pain in Children
N. Engl. J. Med., October 3, 2002; 347(14): 1094 - 1103.
[Full Text] [PDF]


Home page
J Child NeurolHome page
W. W. Wasiewski
Topical Review : Preventive Therapy in Pediatric Migraine
J Child Neurol, February 1, 2001; 16(2): 71 - 78.
[Abstract] [PDF]


Home page
Fam PractHome page
A. Pakalnis
New avenues in treatment of paediatric migraine: a review of the literature
Fam. Pract., January 1, 2001; 18(1): 101 - 106.
[Abstract] [Full Text] [PDF]